Skip to main content
. 2017 Jun 29;8(6):e2897. doi: 10.1038/cddis.2017.288

Figure 7.

Figure 7

A possible mechanism of KDM2B regulation of apoptotic response in GBM cells. KDM2B modulates the H3K36 methylation levels of target proapoptotic genes to suppress their expression levels. RNAi-mediated knockdown or TRAIL-sensitizing agents downregulate KDM2B, which in turn lead to sensitization of GBM cells by increased transcription of proapoptotic genes. In accordance, silencing of HMTs responsible for the same histone modification confers GBM cells more resistant to TRAIL-induced apoptosis